Searched for
CIPLA FAMILY STAKE
Cipla's vice-chairman MK Hamied resigns citing age and health, his son Kamil to join the boardCipla's vice-chairman MK Hamied has resigned from the board due to age and health concerns, effective October 29, 2024. His son Kamil Hamie...- Cipla promoters sell 2.53% stake for around Rs 2,600 crorePromoters of Cipla, including Person Acting in Concert, sold 2.04 crore shares in a block deal worth around Rs 2,600 crore to create liquid...
- Cipla promoters to sell up to 2.53% for Rs 2,637 croreThe move, days after the company posted its best annual results, has triggered speculation that more such transactions could be in the offi...
- Promoter entities likely to sell 2.5% stake in Cipla worth Rs 2,637 crore: ReportPromoters of drugmaker Cipla are expected to offload 2.53% of their stake in a block deal worth Rs 2637 crore on Wednesday, according to so...
- Promoter group entities likely to sell 2.5% stake in Cipla worth Rs 2,637 crore via block deals: ReportThe price range of the block is fixed at Rs 1,289-1,357, taking the total deal value to around Rs 2,637 crore.
- Samina Hamied of Cipla steps down from her executive roleSamina Hamied, executive vice-chairperson of Cipla, announced her decision to step down from her executive role due to personal and family ...
- Torrent talks for $7 billion Cipla buyout trip on valuationTorrent Pharma's attempt to acquire the stake of the Hamied family in Cipla has hit a roadblock due to differences in valuation. Talks betw...
- Cipla stake sale plan faces hurdle as promoters differ on valuation: ReportCipla's potential stake sale faces a challenge due to disagreements among its promoters regarding the company's valuation. This dispute amo...
- Cipla founding family’s stake sale in jeopardy over $13 billion valuation targetProspective buyers of a stake in Indian pharmaceutical company Cipla Ltd. are hesitant due to the high valuation demanded by the founding f...
- Why Torrent Pharma is ready to go ahead with the daunting Cipla dealAhmedabad-based Torrent Pharma is seeking financing for a deal with Indian pharmaceutical company Cipla. Torrent Pharma is interested in bu...
- Torrent Pharma says it has no disclosure to make now on potential Cipla stake buy deal reportsTorrent Pharma has stated that it does not have any information to disclose under listing regulations, in response to reports about the com...
- Torrent in top gear to close out Cipla buyout, in talks with PEs, banks for fundsRival contenders Blackstone, Baring Asia hit pause mode as Cipla valuations soar. Torrent taps PE funds like Warburg Pincus, CVC among othe...
- Cipla shares rally over 6% to record high. Here's whyBlackstone may submit a non-binding bid next week for the Hamied family's stake in the company. This will formally start a process which co...
- Cipla patriarch Y K Hamied increases stake in company to over 20%The transfer of shares is being done by way of gift, the filing said, adding that the purpose was "Re-alignment of family shareholding".
- YK Hamied to increase stake in Cipla to over 20 per centCipla patriarch YK Hamied plans to increase his holding to over 20 per cent by acquiring over 5 per cent additional stake in the homegrown ...
- Cipla promoters to decide on family pact in 'due course'All promoters put together hold 36.8 per cent stake in Cipla, while Yusuf Hamied individually owns 15.55 per cent. His sister Sophie holds ...
- Cipla promoter family gets Sebi go-ahead for voting agreementCipla's promoter family has proposed to vote together as a single unit under overall direction of patriarch Yusuf Hamied in his lifetime, a...
- Hamsons buys 21% stake in Okasa PharmceuticalsWhile Cipla paid Rs 29 crore for Okasa’s facility in Goa, it bought another plant, owned by Okasa Pharma, located in Satara for Rs 71.93 cr...
- Hamied family company buys out minority shareholders in OkasaThe acquisition is part of a two-way transaction under which the Yusuf Khwaja Hamied-run Cipla's wholly-owned arm Medispray Laboratories co...
- Cipla promoters not selling out,Co plans to scale up revenuesPharma major Cipla on Thursday said it is expecting to scale up its revenue by over six times to Rs 15,000-20,000 crore.
Load More
